CRISPR Therapeutics AG (CRSP)
NASDAQ·Healthcare·Biotechnology
$50.01
-0.44%
Mkt Cap $4.84B
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (27 analysts)
$63.00
Range $33.00 – $82.00
Implied Upside
+26.0%
Consensus $63.00 vs current $50.01
NASDAQ·Healthcare·Biotechnology
$50.01
-0.44%
Mkt Cap $4.84B
Buy
6
Hold
1
Sell
0
Price Target (27 analysts)
$63.00
Range $33.00 – $82.00
+26.0%
Consensus $63.00 vs current $50.01